Numerous studies show that, within the tumor microenvironment, STAT3 signaling induces pro-carcinogenic cytokines (such as IL-6, IL-10, and IL-23) and inhibits anti-carcinogenic cytokines (e.g., IL-12), thereby promoting tumor immune evasion and cancer progression [72]. The gene discussed is IL23A; the disease is neoplasm.